Johnson & Johnson raised its full-year sales and earnings outlook after revenue rose 5.6% in the first quarter
Johnson & Johnson raised its full-year sales and earnings outlook after revenue rose 5.6% in the first quarter, lifted by demand for everything from Tylenol and Imodium to the company’s pharmaceutical products.
The New Brunswick, N.J., healthcare-products company also said Tuesday that first-quarter earnings were wiped out by a
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Johnson & Johnson beats Q1 consensus estimates and raises guidanceJohnson & Johnson’s stock rose 1.4% in premarket trade Tuesday, after the consumer health and pharma company beat consensus estimates for its first quarter...
続きを読む »
JNJ Stock Price | Johnson & Johnson Stock - Investing.comGet today's JNJ stock price and latest Johnson & Johnson stock news as well as JNJ real-time stock quotes, technical analysis, full financials and more.
続きを読む »
Asian Stock Market: Mostly bearish amid volatility inspired by quarterly result season, oil attempts recoveryAsian Stock Market: Mostly bearish amid volatility inspired by quarterly result season, oil attempts recovery – by Sagar_Dua24 Asia China Nikkei Oil BOJ
続きを読む »
Ericsson's quarterly core profit beats expectationsSweden's Ericsson on Tuesday reported first-quarter core earnings that beat expectations as stronger sales of 5G equipment in countries such as India offset lower sales in high-margin countries.
続きを読む »
India boosts Ericsson's quarterly profit as US dials downSweden's Ericsson on Tuesday reported first-quarter core earnings that beat expectations, supported by stronger sales of 5G equipment in countries such as India, but sales in more established markets fell and eroded margins.
続きを読む »
Privacy, scaling drives use cases for zero-knowledge technologyA quarterly report highlights key drivers of zero-knowledge technology adoption in the blockchain space.
続きを読む »